{"id":488,"date":"2025-07-31T06:05:40","date_gmt":"2025-07-31T06:05:40","guid":{"rendered":"https:\/\/aiwithprompts.com\/?p=488"},"modified":"2025-08-01T00:20:45","modified_gmt":"2025-08-01T00:20:45","slug":"tempus-ai-stock","status":"publish","type":"post","link":"https:\/\/aiwithprompts.com\/?p=488","title":{"rendered":"Tempus AI Stock: Is This the Next Big Opportunity in Healthcare AI 2025?"},"content":{"rendered":"\n
\"Tempus<\/figure>\n\n\n\n

Today in the AI world, Tempus AI stock is gaining worldwide attention in the healthcare AI sector. In this article, we examine its business, stock potential, and whether it belongs in your investment, in 2025.<\/p>\n\n\n\n

What Is Tempus AI?<\/h2>\n\n\n\n

Tempus AI is a deep-edge health technology company<\/strong> that uses artificial intelligence to achieve good results in cancer diagnosis, treatment, and patient outcomes<\/strong>. By combining clinical data with machine learning, Tempus helps doctors make more accurate decisions in real time and give better results.<\/p>\n\n\n\n

Tempus AI is a Stock Ticker TEM (NASDAQ) industry working in Artificial Intelligence, Healthcare, founded in 2015. The company head is Eric Lefkofsky. The headquarters are located in Chicago, Illinois, USA, and the company Focus Area is Precision medicine using AI and big data gives better results.<\/p>\n\n\n\n

Why Is Tempus AI Stock Gaining Investor Attention?<\/h2>\n\n\n\n

Unique Niche in Healthcare AI<\/h3>\n\n\n\n

Tempus is not just another AI technology company; it\u2019s focused on life-saving technology<\/strong> in the $6 trillion healthcare market. That\u2019s a high-level edge for the investor.<\/p>\n\n\n\n

Data Is the New Gold<\/h3>\n\n\n\n

Tempus collects terabytes of collective clinical and geometric data<\/strong>. That massive dataset feeds its AI models, creating a deep motion against future competitors.<\/p>\n\n\n\n

Strong Leadership<\/h3>\n\n\n\n

As its founder, Eric Lefkofsky has developed Tempus- a company he built with a vision that empowers it to have the ability to nurture and grow into a company that becomes an excellent and profitable enterprise by 2025-right next to being co-founder of Groupon..<\/p>\n\n\n\n

IPO Momentum<\/h3>\n\n\n\n

Since its IPO in June 2024, Tempus AI stock has been on investors’ radar as a high-potential growth stock<\/strong> especially among those term of bullish on healthcare innovation.<\/p>\n\n\n\n

Key Strengths of Tempus AI<\/h2>\n\n\n\n

AI-powered diagnostics<\/strong> that reduce homework in treatment<\/p>\n\n\n\n

Strong partnerships with hospitals and research institutes<\/strong><\/p>\n\n\n\n

Scalable data business model<\/strong><\/p>\n\n\n\n

Tempus AI Stock Performance of July 2025<\/h2>\n\n\n\n
Organized<\/th>Value<\/strong><\/th><\/tr><\/thead>
Stock Price<\/td>$46.75<\/td><\/tr>
Market Cap<\/td>$9.8 Billion<\/td><\/tr>
52-Week Range<\/td>$28.40 – $48.10<\/td><\/tr>
P\/E Ratio<\/td>Not profitable till 2025<\/td><\/tr>
Revenue <\/td>$675 Million<\/td><\/tr>
YOY Revenue Growth<\/td>+62%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Any Risks to Be Aware Of?<\/h2>\n\n\n\n

Like any emerging technology stock, Tempus AI is not risk-free<\/strong>.<\/p>\n\n\n\n